Thousands of poorest Scots to receive free weight-loss jabs in trial

Dr. George F. Tidmarsh, the chief of the FDA's drug unit, has been placed on leave, citing a 'toxic' work environment stemming from disagreements over a new program aimed at speeding up medication approvals. This situation highlights the internal conflicts within the agency, which could impact the timely approval of essential drugs, ultimately affecting public health.

The FDA has decided to restrict the use of fluoride supplements for children, highlighting emerging health risks associated with their use. This decision is significant as it reflects growing concerns about the potential negative effects of fluoride on young children's health, prompting parents and caregivers to reconsider the necessity of these supplements in dental care.

Thousands of South Sudanese refugees and impoverished locals in Uganda were filled with hope thanks to a new USAID-funded project that promised financial support and business coaching. However, their dreams were dashed when funding cuts were announced, leaving many without the lifeline they desperately needed to escape poverty. This situation highlights the fragility of aid programs and the impact of budget constraints on vulnerable communities.

The Traitors star has expressed gratitude for a rare medical condition that ultimately led to a crucial diagnosis after enduring years of pain. This story highlights the importance of medical awareness and how unusual health issues can sometimes provide answers that improve quality of life. It's a reminder that even challenging situations can lead to positive outcomes.

This weekend's time change offers a great opportunity for teens to reset their sleep schedules and improve their overall sleep quality. Experts suggest that adjusting to the new time can help teens establish healthier sleep habits, which are crucial for their development and well-being. With practical tips from sleep doctors, parents can support their teens in making this transition smoother, ensuring they get the rest they need to thrive.

Novo Nordisk and Pfizer are in a fierce and desperate competition for the obesity-drug assets of Metsera, highlighting the intense pressure in the pharmaceutical industry to secure effective treatments for obesity. This battle not only reflects the high stakes involved in the obesity market but also raises concerns about the lengths companies will go to in order to gain an edge, potentially impacting innovation and pricing in the sector.